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ABSTRACT
Type II restriction-modification (R-M) systems com-
prise a restriction endonuclease (REase) and a
protective methyltransferase (MTase). After R-M
genes enter a new cell, MTase must appear before
REase or the chromosome will be cleaved. PvuII and
some other R-M systems achieve this delay by
cotranscribing the REase gene with the gene for an
autogenous transcription activator (the controlling
or ‘C’ protein C.PvuII). This study reveals, through
in vivo titration, that C.PvuII is not only an activator
but also a repressor for its own gene. In other
systems, this type of circuit can result in oscillatory
behavior. Despite the use of identical, symmetrical
C protein-binding sequences (C-boxes) in the left
and right operators, C.PvuII showed higher in vitro
affinity for OL than for OR, implicating the spacer
sequences in this difference. Mutational analysis
associated the repression with OR, which overlaps
the promoter  35 hexamer but is otherwise dis-
pensable for activation. A nonrepressing mutant
exhibited poor establishment in new cells. Compar-
ing promoter-operator regions from PvuII and 29
R-M systems controlled by C proteins revealed
that the most-highly conserved sequence is the
tetranucleotide spacer separating OL from OR.
Any changes in that spacer reduced the stabil-
ity of C.PvuII-operator complexes and abolished
activation.
INTRODUCTION
Many bacteria possess restriction-modiﬁcation (R-M)
systems (1), at least in part for defense against DNA
bacteriophages. The great abundance of R-M systems in
the prokaryotic world reﬂects their mobility via transfor-
mation, transduction or conjugation (2,3). The PvuII R-M
system is carried on a plasmid (4,5). Like other type II
systems (6), it includes two separate enzymes: a restric-
tion endonuclease (REase) that cleaves DNA at a target
sequence, and a methyltransferase (MTase) that modiﬁes
the same sequence to protect it from the cognate REase
(7–12). There is evidence that some R-M systems behave
as addiction modules, with REase as ‘toxin’ and MTase as
protective ‘antitoxin’ (13) [and, for that matter, that some
addiction modules play anti-bacteriophage roles (14)].
The REase and MTase must be carefully balanced,
ideally in a relatively host-independent manner, to mini-
mize killing of new host cells that initially have completely
unmethylated chromosomes. Even after establishment
in a new host, on the one hand too much methylation
could lead to several problems. First, overmethylation
would increase the ‘escape rate’ (bacteriophage becoming
methylated before restriction can occur) (15). Second,
overexpression of the MTase would undermine the post-
segregational killing associated with the selﬁsh behavior
of R-M systems (16). Third, changes in DNA methylation
can have broad eﬀects on gene expression patterns
(17–19). Finally, under some circumstances, overmethyla-
tion can even lead to mutation (20,21). On the other hand,
too much REase would lead to possibly-lethal DNA
damage (22,23). Despite the importance of this balance,
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Numbering is relative to the initiation codon of pvuIIC. The four gray rectangles represent the C-half-boxes (shaded in part A). The two transcription
starts for pvuIICR are identiﬁed by rightward bent arrows: from the C-independent weak promoter (thin) and C-dependent strong promoter (thick)
(43). The two pvuIIM promoters are also shown (leftward bent arrows). (B) Comparison of the regions upstream of conﬁrmed and putative C protein
genes. Genes were identiﬁed by using the Blink function of Entrez (92), and REBASE (1), with the C.PvuII amino acid sequence as seed. This set was
then screened for two features: proteins with predicted recognition helix sequences (of the helix–turn–helix motif) similar to that of C.PvuII (HRTYI)
(41) or of C.AhdI (DR
T/SY) (52), and being part of a putative R-M system (usually indicated by an adjacent MTase gene, as REase genes are
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well as defense against bacteriophages (24), the regulation
of R-M system gene expression is still not well understood,
though progress is being made [e.g. (25,26)].
In addition to the MTase and REase genes, a subset
of type II R-M systems contains regulatory genes. The
regulatory C (controlling) gene was ﬁrst discovered in the
PvuII (27) and BamHI (28) R-M systems. Subsequently,
active regulatory genes have been demonstrated in the BclI
(29), BglII (30), Esp1396I (31), EcoO109I (32), EcoRV
(33), Eco72I (34), HgiAI (35), BstLVI (36), Kpn2I (37)
and SmaI (38) R-M systems. The C proteins appear
to have a remarkably broad host range; for example a
C-protein from the Gram-positive bacterial genus Bacillus
activates transcription in Escherichia coli (38).
C proteins, where tested, activate their own transcrip-
tion (‘autogenous’ activation), and are believed to be
responsible for the delay in REase activity that is crucial
when an R-M system enters a new host cell. In R-M
systems having a C gene, the REase gene typically does
not have its own promoter (an exception is LlaI (39)).
The C and REase open reading frames usually overlap
(as in the PvuII system; Figure 1A), and the REase gene is
completely dependent on transcription from the upstream
autogenously regulated C gene (40). Disruption of pvuIIC
leads to a drastic reduction in REase expression that is
restored by supplying the C gene in trans (27,41). Thus, in
a new cell, REase expression should be low until C protein
accumulates. The role of this activation requirement
in delaying REase expression is indicated by the observa-
tion that pre-expressing C protein prevents transformation
by the intact cognate R-M system, presumably due to
premature REase expression and cleavage of recipient
cells’ chromosomal DNA (13,40).
R-M systems-associated C proteins fall into several
groups based on their sequences and (to the extent this is
known) DNA sequence speciﬁcities. The archetypes of
three currently recognized groups are C.PvuII, C.EcoRV
and C.EcoO109I (R.M.B., unpublished data). All of them
share a helix–turn–helix DNA-binding motif (predicted, in
mostcases).TheﬁrstsolvedcrystalstructureofaCprotein,
C.AhdI of the C.PvuII group, strongly resembles the
N-terminal DNA-binding domains of the Xre family of
transcription factors, a group that includes the well-studied
 cI and 434 repressors (42). The similarity has been
conﬁrmed by the structure of C.BclI (29). Comparisons
of C and RpoD amino acid sequences (41,43) and
structures (C.AhdI structure docked with those of DNA
from the  cI–DNA complex and of RpoD) (42) suggest
that C proteins may activate transcription through direct
contact with the s
70 subunit of RNA polymerase.
The C proteins act on conserved operator sequences
called ‘C-boxes’ (40,44). Conserved sequences upstream of
C genes were ﬁrst noted in a study of the Eco72I RM
system (34). Functional C-boxes have been determined for
C.PvuII (40), C.AhdI (45), C.EcoRV (33), C.EcoO109I
(32) and C.BclI (29), though details of C protein inter-
action with this DNA and with RNA polymerase have yet
to be reported. Recently sequenced bacterial genomes
are revealing many putative C protein-like open reading
frames (ORF), and upstream C-box sequences. We have
updated and expanded an analysis of C-box/promoter
regions for the PvuII-like group of C proteins (40,43), as
shown in Figure 1B, C. The C-box position varies relative
to the C ORF start codon, but the box regions all resemble
two pairs of symmetrical inverted repeats linked by a 4nt
spacer (43): GACT-(N3)-AGTC-(N4)-GACT-(N3)-AGTC
(Figure 1B). Logo analysis (46) reveals that the central
base pairs (GT) of this 4nt spacer are more highly
conserved than the symmetry elements themselves
(Figure 1C) (43). Strikingly, when the C proteins are
divided based on their recognition helices, the group falls
into two distinct subsets, in which the central spacer is
predominantly TGTA for the HRTY helix and CGTG for
the DR
T/SY helix (Figure 1B, C).
The palindromic nature of C-boxes suggests that each
of the two C-boxes (designated as 1AB or OL - operator
left, and 2AB or OR - operator right; Figure 1D) could
each be bound by the helix–turn–helix motifs of a
C protein homodimer (47). The two operators have
center-to-center spacing of 15bp (Figure 1B) (40,43),
meaning that the two C homodimers would occupy
opposite faces of the DNA double helix (48), similar to
repressor DtxR (49).
The C-boxes are located amid two overlapping promo-
ters for C gene transcription (33,43). For the PvuII R-M
system (40,43), the two transcription start sites have been
determined by primer extension and nuclease S1 mapping
(arrows in Figure 1D). The transcript starting within
half-box 2B (OR) is produced from a weak, C-independent
promoter believed to be responsible for initial C.PvuII
production when the R-M system enters a new cell. The
second, leaderless mRNA (50,51) comes from a strong,
C-activated promoter (40,43). The complexity of this
regulatory region is reﬂected by the fact that a 12bp DNA
segment includes the 1B and 2A half-box elements,
together with the central spacer (TGTA), the  10
hexamer for the weak promoter, and the  35 hexamer
for the strong, C-dependent promoter (Figure1D).
The roles of particular C-box elements have not
been clear. Two C proteins, C.AhdI and C.EcoRV, have
higher in vitro aﬃnities for OL than OR (33,45), and OL
diﬃcult to recognize). A question mark indicates an ORF not yet formally named (93). The C protein initiation codon is underlined, unless it starts
farther downstream. For C.PvuII (top), the underlined nucleotides (in half-box 2B and at the C.PvuII initiation codon) indicate the previously-
identiﬁed transcript starts (40,43). The shaded nucleotides indicate actual or predicted C-boxes, and the proposed symmetrical core (40,43) is shown
at the bottom. (C) Sequence Logos for the two subsets of C-box/promoter regions associated with C proteins having HRTY (upper) or DR
T/SY
(bottom) in the recognition helix. The Logo (46) was obtained from the two subsets of sequences in panel A, generated by the server at: http://
weblogo.berkeley.edu. In Logo analysis, the full height (two bits of information content) applies to completely conserved positions. The C-box
elements are boxed. (D) The pvuIIC promoter region sequence showing the C-box and promoter elements. The palindromic operators each contain a
pair of C-boxes, designated as boxes 1AB or OL (operator left), and 2AB or OR (operator right). Conserved elements of the stronger, C-dependent
promoter are indicated by heavy rectangles, while thinner rectangles indicate the weak C-independent promoter. Transcript starts are indicated as in
(A). The upper sequence is from the wild-type (WT) PvuII R-M system, while the lower sequence has one substitution each in half-boxes 1A and 2A
such that they match the symmetrical cores (SC) shown at the bottom of (B).
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The close proximity of C-box and promoter sites led to a
proposal that C protein and RNAP compete for binding,
such that C protein binding to OL activates transcription,
while binding to OR leads to repression (45,52). However
the C proteins are remarkably small (monomer MW
of 9.4kDa, for C.PvuII), and at OR might act like the
AsiA/MotA coactivators of bacteriophage T4, allowing
RpoD interactions at  10 but replacing them at  35 by
‘remodeling’ the RpoD (53,54). Other activator–RNAP
complexes, or certain  35/ 10 spacer sequences, can also
functionally replace the  35 hexamer (55,56), which is one
possible explanation of the observation that the spacing
between pvuIIC C-boxes/putative  35 hexamer and the
 10 hexamer could be varied by  4bp with little eﬀect
(43), in sharp distinction to most promoters (57). Thus,
we could not rule out an alternative regulatory model in
which the occupation of all four half-boxes is required for
full activation; this arrangement could in theory make the
control system respond to rising C.PvuII levels as a rela-
tively irreversible switch (58). To distinguish between this
model and the activation-repression model, and to study
the roles of the C-boxes, we carried out a series of in vivo
and in vitro experiments. Our results strongly support
the autogenous activator-repressor model, consistent with
what had been proposed on theoretical grounds for
C.AhdI (45,52), and indicate that this regulatory circuit
is more than a simple switch.
MATERIALS AND METHODS
Strainsand plasmids
The E. coli K-12 strains used in this study are described
below. All strains into which pvuIIM is introduced must
lack the mcrBC restriction system (4,59,60). MC1061
[araD139 (ara, leu)7697, lacX74, galU, galK, hsdR,
strA] (61) transports arabinose but is deﬁcient in its
metabolism; it was used as the host for in vivo titrations
with C.PvuII. TOP10 [F
  mcrA( mrr-hsdRMS-mcrBC)
80lacZM15 lacX74 recA1 ara139 (ara-leu)7697 galU
galK rpsL (Str
R) endA1 nupG] (Invitrogen) was used for all
other purposes including cloning steps and CAT assay.
BL21(DE3) was used for C.PvuII puriﬁcation, as it
contains the gene for phage T7 RNA polymerase under
an inducible promoter (62). The plasmids used are listed in
Table 1. The oligodeoxyribonucleotides used are shown
in Table S1 of the Supplementary Data.
Invivo titration of C.PvuII
All experiments were performed in MOPS-minimal
medium (Teknova) with 0.2% glycerol or 0.2% glucose
as carbon source (63). The minimal media were supple-
mented with 2mg/ml thiamine and 40mg/ml each of the
L-amino acids Ala, Arg, Glu, Gly, His, Ile, Leu, Lys, Met,
Pro, Ser and Val. Single colonies were used to inoculate
overnight cultures in MOPS media containing 0.2%
glucose and appropriate antibiotics. These cultures were
diluted 1:50 into the same medium but without antibiotics,
and grown with shaking to an OD600nm of 0.2–0.3. The
cells were then gently pelleted, resuspended and divided
among ﬂasks containing MOPS-minimal media with
varied concentrations of L-arabinose.
b-Galactosidase assay
The LacZ assay was based on hydrolysis of
O-nitrophenyl-b-D-thiogalactoside (64) as modiﬁed by
others (65). Brieﬂy, b-galactosidase activity and culture
density were measured at 20–30min intervals during
exponential growth. The units for this assay were calcu-
lated by dividing the measured A420nm (released nitro-
phenol) by the time allowed for the reaction and by
the volume of permeabilized cells used for the reaction.
The units of b-galactosidase activity are arbitrary units:
1000 A420nm min
 1ml
 1. The speciﬁc activity was
obtained by determining the slope of a plot of
b-galactosidase activity versus the OD600nm culture density
via linear regression.
C proteinpurification
C.PvuII was expressed from plasmid pMal.CPvuII, in
which the PCR-ampliﬁed pvuIIC gene (primers C1, C2)
from pPvuRM3.4 (4) was ligated into the XmnI and SalI
sites of plasmid pMal-c2x (New England Biolabs, MA).
In pMal.CPvuII, pvuIIC is translationally fused to malE
(maltose-binding protein, MBP). The signal sequence for
malE has been deleted, so the fusion protein remains in
the cytoplasm. The host was E. coli strain BL21(DE3),
cultivated in 1l LB medium supplemented with ampicillin
(100mg/ml) and 0.2% glucose at 378C. When the cell
density reached an OD600nm of 0.5, overproduction
of C.PvuII was induced by adding IPTG to 0.5mM.
After 3h incubation, cells were pelleted and stored at
 708C until used. Frozen cells were thawed in C buﬀer
(20mM Tris–HCl, pH 7.4, 200mM NaCl, 1mM EDTA)
and sonicated (20 10s in a cup horn probe). The
centrifugally clariﬁed lysate was applied to a 2.5 10cm
amylose resin column (New England Biolabs), and bound
fusion protein eluted with 60ml of 10mM maltose in
C buﬀer. Protein-containing fractions were pooled and
digested overnight with Factor Xa protease (1mg per
100mg fusion protein) at room temperature to cleave the
MBP from C.PvuII. The digest was concentrated in an
Amicon Ultra-15 centrifugal ﬁlter unit (5kDa MW cutoﬀ;
Millipore). Then gel ﬁltration chromatography was used
to separate C.PvuII from MBP. A Superose-12 column
(Amersham-GE) was equilibrated with S buﬀer (20mM
Tris, pH 8.0 and 100mM NaCl), and the protein sample
was loaded. C.PvuII fractions were pooled, concentrated
again in Amicon ﬁlter units and stored in 20% glycerol at
 208C. About 2.2mg C.PvuII was obtained with purity
>99% as assessed by SDS–PAGE.
Generation and analysis ofrandomized libraries
Oligodeoxyribonucleotides L1, L2 and L3 (IDT, Iowa)
span the region upstream of the pvuIIC initiation codon,
and include four consecutive randomized positions each:
L1: the spacer between half-boxes 1B and 2A, L2: half-box
2A (with 2B wt) and L3: half-box 2A (with 2B as the
reverse complement), as described in Table S1 and
Figure S1. Oligodeoxyribonucleotide UP was used to
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oxyribonucleotides (L1 and UP for the spacer library,
L2 and UP for the WWNW library, or L3 and UP for the
WWNR library) were hybridized, and the shorter primer
was extended with Klenow polymerase. The DNA was
digested with BamHI and SalI, and ligated into pDK178
(which contains PpvuIICR from  91 to  1 relative to the
initiation codon of pvuIIC,i nt h ecat promoterless
vector pKK232-8). This plasmid was electroporated into
E. coli TOP10 cells, and plated onto LB agar containing
carbenicillin (Cbn, 50mg/ml). Transformants were pooled,
and plasmid DNA was recovered with the midi plasmid
kit (QIAGEN). The library DNA was electroporated into
an E. coli strain containing pDK200 (a pACYC184-based
plasmid that speciﬁes pvuIIC, but not pvuIIR or pvuIIM),
and colonies were selected on plates containing Cbn and
chloramphenicol (Cml), with the latter at either 20 or
120mg/ml. To isolate nonrepressing mutants, the library
plasmids were introduced into E. coli MC1061 carrying
pIM4, and transformants were plated onto solid MOPS-
minimal medium supplemented with 0.2% arabinose and
80mg/mlCml. Under these conditions, a large (repressing)
amount of C.PvuII protein is made, so only nonrepressing
mutants will express cat, and C.PvuII-independent
mutants are eliminated by screening. Plasmid DNA was
isolated from resultant colonies, and the 4nt randomized
region was determined by sequence analysis.
Chloramphenicol acetyltransferase (CAT) assay
The CAT ELISA kit (Roche) was used to colorimetrically
quantitate CAT reporter levels based on a sandwich
ELISA method. The recommended protocol was followed
with some modiﬁcations. The culture was grown in LB or
MOPS-minimal medium until the OD600nm reached 0.3.
Samples (1ml each) were removed and, after pelletting,
the cells were resuspended in 0.5ml of lysis buﬀer
(100mM K/PO4 pH 7.8, 1% Triton X-100, 5mg/ml
BSA, 1mM DTT, 5mg/ml lysozyme) and kept for 20min
at RT. The centrifugally cleared cell extracts were diluted
1:50 and loaded onto microplate modules with anti-CAT
antibodies prebound to the surface. CAT concentra-
tion was calculated as nanogram per microgram of total
protein. The total protein concentration was determined
with the RC/DC kit and protocol (Bio-Rad).
Electrophoretic mobility shift assays (EMSA)
DNA substrates were 50-biotinylated, double-stranded
PCR-ampliﬁed fragments (primers: emsa1, 2), that
included the entire PpvuIICR region (wt or mutant as
indicated). For a nonspeciﬁc DNA substrate, having no
C-boxes but of the same size as the other substrates,
primers emsa3, 2 were used (Table S1). This primer pair
ampliﬁed DNA from the polylinker region of the vector
pKK232-8 (GenBank #U13859)(66). Reactions containing
20nM DNA and the indicated protein concentrations
were prepared in binding buﬀer [50mM Tris–HCl
(pH 8.0), 1mM DTT, 10mM MgCl2, 2.5% glycerol] in
a ﬁnal volume of 20ml, and incubated for 20min at 228C.
Samples were electrophoresed on 10% native polyacryl-
amide gels in 0.5 TBE buﬀer for 90min at 100V at 228C.
The location of dsDNA in the gels was determined
either via ethidium bromide staining and photography
with UV transillumination, or DNA was transferred by
electroblotting to positively charged nylon membranes
Table 1. Plasmids used in this study
Name Relevant feature(s) Reference
pACYC177 Cloning vector (Amp
R, Kan
R) (90)
pBAD24 Arabinose inducible araBAD promoter, araC, Amp
R, ColE1 ori (68)
pBR322 Cloning vector (Amp
R, Tet
R) (91)
pDK200 wt pvuIIC gene with its own promoter, ipvuIIM, ipvuIIR, Tet
R, p15A ori (43)
pDK201 As pDK201, but pvuIIC-Esp19 mutation (43)
pDK178 (WWWW) Transcriptional fusion of pvuIIC promoter including C-boxes with the symmetrical core -
WWWW (GATCcat AGCTtgtaGACTcaaAGCT) to the cat gene in pKK232-8
D. Knowle, unpublished
pDK435 Transcriptional fusion of pvuIIC promoter including wt C-boxes (positions  93 to +88) in front
of promotorless lacZ reporter gene in pKK232-8, Tet
R, p15A ori
D. Knowle, unpublished
pIM1 pvuIIC under control of araBAD promoter in pBAD24, Amp
R, ColE1 ori This study
pIM2 Kan cassette inserted to break bla gene in pIM1, Kan
R, ColE1 ori This study
pIM4 As pIM2 but p15A ori This study
pIM6 Nonrepression mutant, as pPvuRM3.4, but C-box (GACTcatAGTCtgtaGACTcaaGATC) This study
pIM8 As pDK435, but symmetrized C-box, as for pDK178 This study
pIM9 As pDK435, but C-box sequence as for pIM6 This study
pKK232-8 Promotorless cat reporter gene (66)
pMal-c2x Vector for puriﬁcation of protein fused to malE (maltose-binding protein) New England Biolabs
pMal.CPvII Translational fusion of pvuIIC::malE in pMal-c2x This study
pPvuRM3.4 wt PvuII R-M system in pBR322 backbone (4)
pPvuM1.9-ACYC As pPvuM1.9 (M+R-C-), but p15A ori (4)
pRWWW As pDK178, C-box–RWWW (TCAGcatAGTCtgtaGACTcaaAGCT) D. Knowle, unpublished
pWWWR As pDK178, C-box–WWWR (GACTcatAGTCtgtaGACTcaaCTGA) D. Knowle, unpublished
pWWRW As pDK178, C-box–WWRW (GACTcatAGTCtgtaTCAGcaaAGTC) D. Knowle, unpublished
pWRWW As pDK178, C-box–WRWW (GACTcatCTGAtgtaGACTcaaAGCT) D. Knowle, unpublished
UL3 (WWRR) As pDK178, C-box–WWRR (GACTcatAGTCtgtaTCAGcaaCTGA) This study
UL4 (RRWW) As pDK178, C-box–RRWW (TCAGcatCTGAtgtaGACTcaaAGCT) This study
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immobilized onto the membrane by ultraviolet (UV)
cross-linking. Detection of the biotin end-labeled DNA
was performed using the North2South Chemiluminescent
Hybridization and Detection Kit (Pierce) as recom-
mended, and the CCD camera of the Omega Molecular
Imaging System (UltraLum). For competition experi-
ments, the unlabeled DNAs were used at 1-, 2.5-, 5-, 10- or
20-fold molar excess followed by addition of C protein,
electrophoresis and analysis as described above.
Westernblot analysis
For each sample, equal volumes of culture were centri-
fuged at 16000g for 2min. The supernatants were
removed and the cell pellets stored at  808C until analysis.
Pellets were resuspended in 1  SDS buﬀer (Novagen),
and lysed by heating to 988C for 10min. Total protein
concentration was determined using the RC/DC kit and
protocol (Bio-Rad). Equal amounts of protein were
loaded onto a 4–12% Bis–Tris NuPAGE Novex gradient
gel (Invitrogen) and electrophoresed at 100V in
1 NuPAGE MES buﬀer (Invitrogen). Proteins were
then electroblotted to PVDF membranes at 30V for 1h
using an Xcell apparatus (Invitrogen). Proteins were
detected by ﬂuorescence using the ECL-plus Western
Blotting Detection System (GE Health Sciences) as per the
manufacturer’s protocol, with 1:1000 dilution of rabbit
anti-C.PvuII polyclonal serum (Strategic Biosolutions),
and a 1:25000 dilution of horseradish peroxidase-
conjugated goat ant-rabbit IgG. Protein bands were
visualized on an Omega Molecular Imaging System
(UltraLum). The prestained MW markers used were
SeeBluePlus (Invitrogen).
Efficiency oftransformation (EOT) assay
EOT is deﬁned in this study as the relative number
of transformants obtained, using the same amount of
plasmid DNA, from the test strain compared with the
number of transformants obtained from the reference
strain. This term is equivalent to the term ‘relative
transformation eﬃciency’. For plasmid transformation,
the standard CaCl2-heat shock method was used (67) with
plasmid DNA amounts that were nonsaturating.
RESULTS
Accumulation of C.PvuII leads to strong repression
To examine the DNA-binding sites important for activa-
tion of the promoter for the C and REase genes
(PpvuIICR) by C.PvuII, we ﬁrst tested the eﬀects of an
in vivo titration in which intracellular C.PvuII protein
levels were varied from undetectably low to overexpres-
sion. We used the E. coli araBAD promoter (PBAD), as its
activity can be modulated over a wide range (68–70).
We fused pvuIIC to PBAD, followed by strong transcrip-
tion terminators, to generate plasmid pIM1 (Table 1).
This plasmid also carries the gene for the bifunctional
AraC protein, that represses PBAD in the absence of
arabinose and activates it when arabinose is present.
To reveal the eﬀects of the C.PvuII titration, we cloned the
PpvuIICR region (including wild-type C-boxes, positions
 93 to +88, Figure 1A) upstream of the lacZ reporter
gene (plasmid pDK435 or its variant pIM8 with the
symmetrized C-boxes), generating transcriptional fusions.
The host was E. coli MC1061, which lacks the lac and
ara operons but carries araE for arabinose transport.
Experiments were carried out in minimal media with
concentrations of arabinose from 0 to 0.2% (saturating
induction) (Figure 2A and B). The eﬀects of induction on
C.PvuII levels were conﬁrmed by western blot (Figure 2D,
and I.M. unpublished data), and show the strong non-
linear response to arabinose concentration characteristic
of PBAD (68). Expression of the PpvuIIC-lacZ transcrip-
tional fusion was measured by b-galactosidase assay.
The results were unexpected for a known transcription
activator (27,40). In the absence of glucose, the lowest
achieved induction level of C.PvuII gave the maximal
observed expression of the fusion, with higher levels of
C.PvuII (Figure 2C, D) associated with progressively
lower LacZ expression (Figure 2A). Increases in the
intracellular level of C.PvuII were associated with sub-
stantial reductions in LacZ expression from PpvuIICR.
Speciﬁcally, increasing arabinose from  10
 5 to  10
 3%
gave a several 100-fold decrease in LacZ expression,
ultimately dropping to the range of the vector control
at 0.02% arabinose. Even the absence of arabinose (where
C.PvuII levels were undetectably low) was associated
with signiﬁcantly more LacZ activity than was seen at
high levels of arabinose (Figure 2A). This may reﬂect
the activity of the known C-independent promoter
(Figure 1D), believed to provide starting amounts of
C.PvuII for this positive feedback system (40,43), but the
results indicate the occurrence of repression.
As C.PvuII is known to activate transcription (27,40),
we tested an even lower range of C.PvuII levels to
determine whether this in vivo titration system
shows progressive activation. For this purpose, we used
the same minimal medium and arabinose concentrations,
but added 0.2% glucose. Glucose causes catabolite
repression, that indirectly aﬀects the PBAD promoter via
eﬀects on the promoter for the AraC repressor-activator
gene (71). The combination of glucose and arabinose
resulted in an increase in LacZ expression between 0
and 0.02% arabinose, where it reached a maximum 1.6-
fold increase over the initial expression level (Figure 2B).
Further induction of C.PvuII levels with arabinose led as
before to a sharp drop in LacZ activity, down to
background levels at 0.2% arabinose. Both the WT and
symmetrized PvuII C-boxes yielded the same activity
proﬁle, with slightly lower values for the variant
(Figure 2B). This result clearly indicates that C.PvuII is
both an activator and a repressor. This is the ﬁrst in vivo
demonstration of concentration-dependent activation-
repression by C proteins.
C.PvuII exhibits higher affinityfor OL than forOR
As there are two C-box symmetry pairs (Figure 1), a
straightforward model is that occupancy of one operator
leads to activation, while binding to the other (or to both)
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the AhdI C-dependent R-M system (and indirectly for the
EcoRV system) (33,45). However this model predicts
that there is a signiﬁcant diﬀerence in C.PvuII aﬃnity for
the two operators. Further, C.AhdI had been found to
occupy its two operators with such high cooperativity that
no intermediate (with C.AhdI bound to just one operator)
could be found [see Figure 1 in (45)], that would give
a very narrow concentration range in which activation
could occur. To test the relative aﬃnity of C.PvuII for
OL and OR, we performed C.PvuII–C-box binding
experiments via EMSA.
C.PvuII was puriﬁed to >95% homogeneity
(Figure 3A). For this, pvuIIC was fused at its N-teminus
to malE, which speciﬁes the E. coli maltose-binding
protein (MBP). The fusion protein was puriﬁed by aﬃnity
chromatography and cleaved to separate C.PvuII from
MBP (see Materials and Methods section). Subsequent gel
ﬁltration yielded 35ng of C.PvuII protein per milliliter
of starting culture. The binding reactions varied C.PvuII
concentrations from 0 to 800nM.
The target DNAs were based on the 26nt sequence
containing symmetrical C-boxes, GACT-(N3)-AGTC-
(N4)-GACT-(N3)-AGTC, derived from a comparison of
29R-M systems that specify known or putative C.PvuII
orthologs (Figure 1B, C). The spacers are listed here as ‘N’
to distinguish them from the symmetry elements, but are
themselves conserved (see below), and were unchanged
from the wild-type PvuII sequence (Figure 1D). The WT
PvuII C-boxes diﬀer from this pattern at just two of
16 positions: in half-boxes 1A (GACT!TACT) and 2A
(GACT!GATT). This symmetrized sequence is used as
the reference ‘wild-type’ in subsequent experiments.
Reporter fusion assays indicated that this symmetrized
promoter/operator region was transcribed at similar levels
to the native sequence (43), and with the same activation/
repression proﬁle (Figure 2B); our rationale is that
identical C-box elements in the two operators would
facilitate characterizing any position-speciﬁc diﬀerences in
their roles.
In the ﬁrst set of mutants we prepared, one or more
4nt half-boxes were substituted by the reversed sequence
(GACT!TCAG or AGTC!CTGA). These mutants
were named by indicating W (‘Wild’ symmetrized) or
R (Reversed) for each of the four half-box elements, 50!30
(e.g. RWWW where half-box 1A is reversed). For gel
mobility shift experiments, we used 126bp PCR products
ampliﬁed from the various mutagenized plasmids at
a ﬁxed concentration of 20nM. The C-boxes were located
at the center of the ampliﬁcation product, such that the
26bp C-box segment was ﬂanked on each side by 50bp
of DNA from the PvuII R-M system.
The top two panels of Figure 3B show positive
(WWWW) and negative controls (a 126bp fragment of
an irrelevant sequence). The C.PvuII protein bound
WWWW DNA, yielding a single complex at concentra-
tions  400nM. The binding of C.PvuII to the symme-
trized C-box region (WWWW, complex marked ‘III’) was
characterized by a Hill coeﬃcient of 4.1 (Figure S2). This
result indicates strong positive cooperativity for binding,
and suggests [but does not prove (72)]) that one C.PvuII
Figure 2. In vivo titration with C.PvuII and its eﬀect on pvuIICR
transcription. Cells were grown in minimal media with 0.2% glycerol and
the indicated concentration of arabinose, and supplemented as described
in Materials and Methods section. In addition, the cells were grown
without (A) or with (B) 0.2% glucose. Expression from transcriptional
fusionPpvuIICR:lacZ(pDK435)wasmeasuredasb-galactosidasespeciﬁc
activity,determinedbylinearregressionoftheslopesofthelinesgenerated
by plotting LacZ activity (modiﬁed Miller units) versus optical density of
the culture (Platko et al., 1990). Unconnected points at the beginning of
the curve (panel A) indicate values obtained in glucose with no arabinose.
Closed symbols represent LacZ activity from cells with the native PvuII
C-boxes (circles, pDK435) or its symmetrized variant (diamonds, pIM8),
in the presence of PBAD–pvuIIC (plasmid pIM1); open circles represent
LacZ fusion activity when the vector plasmid (lacking pvuIIC) is present
(plasmid pBAD24). (C) Extracts from the same cultures shown in (A)
were resolved on a 4–12% acrylamide SDS gel. Ten micrograms of total
protein was loaded per lane, except for the MW protein markers in the far
left lane and 150ng of puriﬁed C.PvuII in the far right lane. Lanes 1–7
contained culture samples: 1-glucose, 0% arabinose; 2–0% arabinose;
3–7-increasing concentrations of arabinose, in 10-fold steps, from 0.00002
to 0.2%. The gel was then silver stained and photographed. (D) A parallel
gel to that shown in (C) was electroblotted to a PVDF membrane,
blocked, and probed with polyclonal rabbit anti-C.PvuII antiserum
and then with horseradish peroxidase-coupled goat anti-rabbit IgG.
The positions of the prestained MW markers are indicated by bars.
The expected subunit size of native C.PvuII is 9.4kDa.
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for another C-protein, C.AhdI (45).
We next tested binding to the DNA derivatives
having one or more half-sites reversed. First, an intact
OL was necessary and suﬃcient for enough binding
to eliminate free DNA, at least at the highest concentra-
tions of C.PvuII (Figure 3B, bottom three panels on
left, including WWRW, WWWR and WWRR). However,
mutation of OR had three obvious eﬀects. First, the
amount of C.PvuII required for mobility shift was higher
for the mutants; for example 200nM C.PvuII shifted
about half of the WWWW and virtually none of the
WWRW DNA. Second, complexes with WWRW DNA
yielded multiple bands, suggesting loss of cooperativity;
and third, the bands are smeared, suggesting that the
WWRW complexes are less stable than WWWW
complexes.
Any mutation within OL (RWWW, WRWW or
RRWW, with OR left intact) signiﬁcantly reduced the
association of C.PvuII as revealed by the amount of
unbound DNA remaining (Figure 3B, lower three panels
on right). Nevertheless, the OL single half-box variants
RWWW and WRWW still yield some of the distinct,
major complex (III) corresponding to that observed with
WWWW DNA.
These results imply that C.PvuII has greater binding
aﬃnity for OL than for OR. To conﬁrm this, EMSA
competition studies were performed. Biotin-labeled
WWWW DNA was used with increasing concentrations
of unlabeled competitor WWRR (OL intact), RRWW
(OR intact) or no C-box (as a negative control) DNA with
1-, 2.5-, 5-, 10- or 20-fold molar excess. The results
(Figure 3C) directly demonstrate the higher binding
aﬃnity of OL as WWRR DNA was the stronger
competitor, where a 20-fold excess of competitor resulted
in a 95% loss of the shifted WWWW band. In contrast,
the same amount of RRWW competitor DNA led to only
a 25% loss of the shifted WWWW complex.
Figure 3. C.PvuII protein and its in vitro interaction with wild-type and altered C-boxes. (A) C.PvuII was puriﬁed as described in Materials and
Methods section. MW markers and 1.5mg of C.PvuII were resolved on a 4–12% acrylamide SDS gel and silver stained. (B) A series of 126bp
dsDNA binding targets were prepared by PCR ampliﬁcation, and included in each binding reaction at 20nM. The DNAs were a control sequence
(‘no C-boxes’; ampliﬁed from the polylinker region of the vector plasmid), or contained WT or variant C-boxes ﬂanked on either side by 50bp of
native PvuII sequence. The increasing concentrations of C.PvuII were 0, 100, 150, 200, 300, 400, 600 and 800nM. Reactions were processed
as outlined in Materials and Methods section. ‘WWWW’ indicates that all four C-boxes are WT, where this refers to the proposed symmetrical
C-box sequences (underlined): GACTCATAGTCTGTAGACTCAAAGTC. ‘R’ refers to a reversed variant C-half-box (GACT!TCAG or
AGTC!CTGA), and the position of the R or W refers to C-half-boxes 1A, 1B, 2A and 2B in that order (see Figure 1D). The PvuII background
sequence remains intact. Reactions were resolved on 10% native polyacrylamide gels, and DNA was visualized by staining with ethidium bromide.
The stars and Roman numbers denote positions of unbound DNA and the C.PvuII–DNA complexes, respectively. Bands with the same numbers
correspond to one another when run side by side on the same gel (data not shown). (C) EMSA competition assays were performed using 300nM of
C.PvuII and 20nM of biotin-labeled WWWW C-box 126-mer (as described in the Figure 2 legend). Competitions contained increasing amounts
of unlabeled 126-mer DNA fragments (from 1- to 20-fold molar excess); competitors were RRWW (squares), WWRR (closed circles), or no C-boxes
(open circles, negative control). Following EMSA and electroblotting, the shifted bands for each reaction were visualized and quantiﬁed via
chemiluminescent detection of the biotinylated DNA as described in Methods section.
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the intact4nt spacer between operators OL and OR
The binding studies described above suggest that OL
(half-boxes 1AB) is the primary binding site for C.PvuII.
Since activation precedes repression as C.PvuII levels rise,
both logically and according to the data in Figure 2B,
OL is the likely activation site for pvuIICR transcription.
The simplest model is that OL binding alone mediates
activation, while OR binding is responsible for repression.
However, this simple model provides no role for the 4nt
spacer between OL and OR, that includes the most highly
conserved positions among C-box regions (Figure 1C).
Over 75% (16/21) of the identiﬁed C-box spacer
sequences, from C proteins with an HTRY recognition
helix, have the sequence TGTA, and 28/30 of all sequences
have GT in the central two positions (Figure 1B).
Accordingly, we tested the role of the operator spacer
(TGTA in the PvuII R-M system). This spacer overlaps
the predicted  35 hexamer of the C-dependent promoter
(Figure 1D), raising the question of whether its conserva-
tion is coincidental with this overlap or if the spacer plays
some role in C.PvuII binding.
To test the role of the operator spacer, we generated
a plasmid library in which the 4nt spacer was replaced
with a randomized sequence, and the promoter region
including this modiﬁcation was cloned in front of a
promotorless cat (chloramphenicol acetyltransferase)
reporter gene (details in Materials and Methods section,
and in Table S1 and Figure S1). Electroporation into
E. coli produced about 10
4 transformants, giving
a theoretical  40-fold coverage of the 256-possibility
library. The pooled library was puriﬁed and sequence
conﬁrmed, consistent with randomization where expected
and with no other changes (Figure 4A). This conﬁrmed
library was then electroporated into E. coli cells contain-
ing pDK200, a compatible plasmid that supplies intact
pvuIIC in trans. The objective was to determine which
spacer sequences conferred high-level resistance to Cml,
due to increased cat expression, in the presence, but not
the absence of C.PvuII.
Pilot experiments revealed that the plasmid carrying
the wild-type (TGTA) spacer confers resistance to
120mg of Cml/ml in the presence of C.PvuII, but to only
20mg/ml in the absence of C protein or in the presence
of inactive C protein (mutant pvuIIC Esp19, (41)).
The latter low-level resistance is presumably due to the
weak C-independent promoter (see Figure 1D). Similar
results were obtained for both solid and liquid media. We
thus plated the plasmid library, independently in pvuIIC
 
hosts, onto 20 and 120mg of Cml/ml in parallel. We
obtained about 80-fold more colonies on the lower than
on the higher Cml concentration (data not shown).
Next, individual resistant colonies were picked
and their plasmid DNAs were isolated and digested
with a restriction enzyme to selectively inactivate the
pvuIIC-carrying plasmid. The resultant DNA was used
to transform cells carrying plasmid pDK201, that
produces inactive C.PvuII, followed by screening for
loss of the high-level Cml resistance. Such plasmids
were considered to be subject to C-dependent activation,
and were sequenced. Surprisingly, in 12/12 sequenced
variants giving C.PvuII-dependent activation, the
randomized 4nt spacer combination was strictly limited
to TGTA (Figure 4B). The random probability of
obtaining the single 4nt sequence from this library is
1/256 (1/4
4). The probability of getting 12/12 variants with
the identical sequence by chance is  1.2 10
 29, and
strongly indicates that all four positions are required, at
least in the PvuII R-M system.
We also sequenced >40 clones that were sensitive
to 120mgCml/ml, even in the presence of C.PvuII, but
resistant to 20mg/ml. The resulting Logo shows that none
of the four positions is strongly biased (Figure 4D). Two
variants among the sequenced non-activated clones
maintained 3 out of the 4WTnt, TtTA and cGTA, even
though these changes did not overlap the  35 promoter
hexamer.
To quantitate the eﬀects of these changes on transcrip-
tion activation, we measured CAT protein levels in the
cells by an ELISA assay. The results (Figure 4E) show
that even changing a single base in the operator spacer
reduced promoter activity by 90–95%. To determine
whether this eﬀect is due to impaired C.PvuII binding,
EMSA was performed. The results clearly indicate that
altering even one position in the spacer (cGTA or TtTA;
Figure 4F) impairs C.PvuII binding about as much
as reversing one of the C-box half-sites (Figure 3B).
A nucleoprotein complex formed and migrated at the
position characteristic of the WT DNA sequence. How-
ever, as with the half-site reversals, disappearance of
unshifted DNA occurs at higher C.PvuII concentrations,
an intermediate complex is more pronounced, and band
smearing suggests that the complexes are unstable. Other
tested variants (from among those shown in Figure 4E)
gave similar binding patterns (data not shown). These
results indicate that the TGTA spacer plays a role
independent of the overlapping  35 hexamer.
Half-box 2Bin OR isdispensable for
C.PvuII-dependent activation
If C.PvuII binding to OR is associated exclusively with
repression, then altering that site should not reduce
activation by C.PvuII. To test this prediction, we again
prepared a randomized plasmid library for selection on
plates and CAT reporter assays. We generated two
separate libraries, each of them containing a randomized
half-box 2A in OR. In one library, designated WWNW
(where ‘N’ indicates the randomized 4nt sequence),
the background sequence of the other three half-boxes
and the TGTA spacer remain intact (Figure 5A).
In contrast, the second library, labeled WWNR, includes
a reversed complement of half-box 2B (Figure 5B).
The rationale for producing two libraries (WWNW and
WWNR) derives from the overlap between half-box 2A
and the  35 hexamer of the C.PvuII-activated promoter
(Figure 1D). If OL binding leads to activation and OR
binding leads exclusively to repression, then C.PvuII-
activated variants from the WWNW library should
include sequences that preserve  35 functionality but do
not resemble the GACT C-binding consensus. That is,
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necessarily repression-associated C.PvuII binding. The
 35 hexamer consensus sequence is 50-TTGACA-30, with
a5 0!30 gradient of decreased conservation (57,73,74).
However, if cooperative binding to both OL and OR
(or OL and half-box 2A) is required for full activation,
the randomized half-box 2A should retain similarity to
GACT (as well as to the -35 consensus). The second
library (WWNR) has disrupted C.PvuII binding to OR
in all cases, and should yield C.PvuII-activated variants
only if OR (or at least half-box 2B) plays no role in
activation.
The WWNW and WWNR library analysis followed the
same protocols as for the TGTA spacer library (described
above). Electroporation into E. coli produced about 8000
transformants per library, again assuring full coverage
given the complexity of 256 sequences. Each pooled
library was puriﬁed and sequence conﬁrmed, indicating
Figure 4. Randomized operator spacer library and selected variants. (A) Sequencing trace of the pooled randomized spacer plasmid library before
selection. The randomized spacer lies between C-half-boxes 1B and 2A. The promoter region library is upstream of a promoterless cat gene
(chloramphenicol acetyltransferase). (B) The plasmid library was used to transform an E. coli strain that already carried a compatible plasmid
producing C.PvuII at physiological levels, and transformants were plated onto agar with a high Cml concentration (120mg/ml) to select functional
C.PvuII-activated variants, followed by a screen for reduced resistance in the absence of C.PvuII. The sequencing result is shown, along with the WT
sequence for comparison. (C) Non-activated variants, that grew at a low Cml concentration (20mg/ml) but not at 120mg/ml. Sequences are shown,
with matches to the WT sequence in bold, and alterations in outline. (D) Logo analysis of the Cml-sensitive variants shown in (C). (E) Promoter
activity for selected variants in the presence of physiological steady-state levels of C.PvuII (pvuIIC under native control from plasmid pDK200).
CAT levels were determined in triplicate via immunoassay as described in Material and Methods section. Error bars indicate the SD. CAT levels are
expressed as nanograms of protein per microgram of total protein and then normalized to the WT PpvuIICR-cat level (TGTA). (F) EMSA performed
for WT (TGTA) and three representative variants. The experiments were carried out as in Figure 3B. The stars and Roman numerals denote
positions of unbound DNA and C.PvuII–DNA complexes, respectively.
6944 Nucleic Acids Research, 2007, Vol. 35, No. 20randomization at each of the four positions with no other
changes (Figure 5A, B). For each library, 24 clones
showing C.PvuII-dependent resistance to 120mgCml/ml
were isolated (Figure 5CD).
For the WWNW library, nearly 60% of variants
had the wild-type symmetrical consensus GACT at
half-box 2A. The other activated sequences were GATC,
GAAT and GACG. It thus appears that the C.PvuII
Figure 5. Randomized C-half-box 2A libraries and selected variants. (A) Sequencing trace of the pooled randomized C-half-box 2A plasmid library
before selection. All other C-half-boxes were WT (WWNW, where ‘N’ indicates the randomization), and the promoter region library is upstream of
a promoterless cat gene. (B) Sequencing trace as in (A), except that in this library C-half-box 2B is replaced by the reversed complement
(AGTC!GACT; WWNR). (C) The selection for C.PvuII-activated variants was as described in Figure 4B. The resulting sequences from the
WWNW library, number of variants showing each recovered sequence, and Logo analysis are shown. (D) Sequences that could be activated
detectably as in (C), but for the WWNR library. (E) The isolation of variants that are not detectably activated by C.PvuII was as described in
Figure 4C. The resulting sequences from the WWNW library and Logo analysis are shown. (F) Sequences that are not detectably activated as in (E),
but for the WWNR library. (G) Quantitative evaluation of C.PvuII-activated variants from WWNW (panel C) or WWNR (panel D) libraries.
CAT levels were measured either in the presence of physiological steady-state levels of C.PvuII (pvuIIC under native control on plasmid pDK200;
black bars), or without pvuIIC (white bars). CAT levels were determined via triplicate immunoassays as described in Material and Methods section.
For comparison, mutants with inactive OR (WWRR) or OL (RRWW) were also analyzed. pKK represents vector (pKK232-8) control. The error bars
indicate SDs.
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disfavored). If OR is associated exclusively with repres-
sion, then sequences associated with better C.PvuII
binding should not have emerged from a selection for
C.PvuII-dependent activation. C.PvuII-activated variants
were also obtained from the WWNR library, demonstrat-
ing that half-box 2B is not required for activation. From
this library ﬁve diﬀerent half-box 2A sequences were
recovered, but again the GACT sequence was favored
(38%). A second preferred sequence, unique to that
library, was GACC (50%) with small amounts of GATT
(the PvuII wild type) and GCCA.
We next carried out quantitative analysis of the isolated
WWNW and WWNR library variants, using ELISA to
measure CAT production. The assay was carried out in
cells with or without plasmid pDK200, which supplies WT
C.PvuII. The highest cat expression, in the presence of
C.PvuII, was obtained when half-box 2A had the sequence
GACT (WT) in the WWNW context, or GACT (WT),
GATT, GACG and in the WWNR context (Figure 5G).
Again, it is noteworthy that there is no expression penalty
for a strong C.PvuII-binding sequence at box 2 (or OR
overall).
Surprisingly, while WWWR mutants had substantially-
impaired C.PvuII binding, as judged by EMSA
(Figure 3B), some variants in the WWNR context
produced CAT protein at WT levels (Figure 5G). All
tested variants and WT produced similar basal CAT levels
in the absence of C.PvuII, presumably driven by the weak
C-independent promoter (Figure 1D). RRWW (UL3)
and WWRR (UL4) C-box-cat combinations were also
generated and analyzed as controls (Figure 5G). The
RRWW mutant (inactive OL) cannot drive transcription
in a C-dependent manner, as CAT expression remains at
the basal level whether or not C.PvuII is provided in trans
(Figure 5G). The WWRR mutant (inactive OR) has no
promoter activity at all, presumably due to disruption of
the overlapping -35 hexamer of the C-dependent promoter
and changes immediately adjacent to the  10 hexamer
of the C-independent promoter (Figure 1D).
Several clones from each library that were sensitive
to 120mg/ml Cml (Figure 5E and F) were also sequenced
and analyzed by CAT assay. None of them is able to drive
cat expression above the basal level in the presence of
C.PvuII (data not shown; variants tested were CGTA,
TTTA, TTTC and TTTT). We assessed C.PvuII binding
for selected sensitive variants having one or 2nt changed
in half-box 2A (Figure S3). In all three variants the shifted
complex was smeared, suggesting reduced stability.
Repression is associated withOR
The library selection results shown in Figure 5 did not
address the role of OR in the repression we observed
(Figure 2A and B). To study this, we again used our
randomized plasmid libraries WWNW and WWNR.
These libraries were introduced into cells that contained
plasmid pIM4, that has pvuIIC under the arabinose-
inducible PBAD promoter (Figure 2, Table 1).
Our strategy was to select for Cml resistance in the
presence of high-level C.PvuII induction, so as to isolate
nonrepressing variants (if possible) from the libraries.
Transformants were plated onto MOPS-minimal media
supplemented with 0.2% glycerol, 0.2% arabinose and
80mgCml/ml. This concentration of arabinose led to
very low cat expression in our titration experiments
(Figure 2A).
We obtained no Cml-resistant variants from the
WWNW library, but got many from the WWNR library
(not shown). This result strongly suggests a key role for
half-box 2B in repression. The majority of Cml-resistant
WWNR variants contain half-box 2A sequences that were
already obtained from screening C-dependent variants as
shown in Figure 5D. The two new sequences were GACA
and GACG.
CAT production was determined quantitatively for
selected WWNR variants and, for comparison, some
previously obtained C-dependent variants from the
WWNW library (selected under lower C.PvuII expression
levels; Figure 5G). The measurements were carried out
under two conditions, chosen based on the in vivo
titrations (Figure 2A). The ﬁrst condition favors activa-
tion and maximum cat expression (0% arabinose;
Figure 6A). The second condition favors repression
(0.2% arabinose; Figure 6B). The results for all tested
WWNW variants reveal similar levels of cat expression
in low levels of C.PvuII (Figure 6A and B; white bars).
When the C.PvuII level was increased by induction of its
PBAD promoter, cat expression was signiﬁcantly reduced
in all cases.
In contrast, all Cml-resistant variants from the WWNR
library, which lack an active half-box 2B, show no eﬀect of
the diﬀerent C.PvuII levels on cat expression (Figure 6).
For the half-box 2A variants GACT, GACG and GACA,
the reporter gene expression is even increased ( 3-fold) by
high levels of C.PvuII. This conﬁrms that we have selected
non-repressing variants, and again strongly implicates
half-box 2B in repression. The half-box 2A logo for these
non-repressing WWNR variants is consistent with half-
box 2A providing part of the  35 hexamer in the absence
of repression (Figure 6C).
Impaired establishment of thePvuIIR-M system
in nonrepressing mutants
The nonrepressing mutant WWWR gave about triple
the expression of symmetrized pvuIICR promoter, even
at a low concentration of C.PvuII, as revealed by the cat
reporter gene fusions (Figure 6A). The same mutation
(AGTC!GATC in half-box 2B of OR) was placed
upstream of a lacZ reporter (pIM9), and the in vivo
C.PvuII titrations were performed as had been done
with the WT (pDK435) or symmetrized (pIM8) C-boxes
(Figure 2B). The results (Figure 7A) conﬁrmed that
disruption of half-box 2B prevents repression, and leads
to even greater than wt autogenous activation at higher
C.PvuII concentrations.
As C.PvuII-C-box interactions also control the down-
stream pvuIIR gene, we investigated the physiological
eﬀects of the repression. We introduced the same WWWR
mutation into the complete PvuII R-M system via site-
directed mutagenesis. The resulting plasmid (pIM6)
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from this change and the symmetrization of the other
C-boxes (see Figure 7 legend). To study the eﬀect of
eliminating repression on establishment in new cells, the
intact or nonrepressing versions of the R-M system were
introduced and we determined the EOT. Our hypothesis
was that lack of repression increases amounts of REase
relative to MTase, and thus increases the risk of lethal
damage to the new host’s chromosome. Accordingly, two
sets of competent cells were prepared: one strain carried
the pvuIIM gene (M+; plasmid pPvuM1.9-ACYC),
so the cells were fully protected before the R-M system
was introduced, and the other strain lacked pvuIIM
(M-; pACYC184). Equal concentrations of three types
of plasmid DNA were introduced: pPvuRM3.4 (wt R-M
systems), pIM6 (nonrepressing R-M system) or pBR322
(vector control). The relative EOTs were expressed as
the fraction of obtained colony-forming units (CFUs) for
M
  versus M
+, and then normalized to the pBR322
values. As predicted by the hypothesis, pIM6 plasmid
appears to have a preferentially lethal eﬀect on M
  cells,
as the EOT was  5-fold lower than that in M
+ cells.
(Figure 7B). In contrast, neither the wild-type PvuII
R-M system nor the vector control plasmid showed
any signiﬁcant M.PvuII-dependent diﬀerence in EOT
(Figure 7B).
This result helps to explain our observation that the
nonrepressing clone (pIM6) could be obtained only when
we used premethylated (M
+) competent cells for trans-
formation with our ligation reactions (I.M., unpublished
data). In M.PvuII
  competent cells, the clones we
obtained had large rearrangements near the introduced
mutation. The transformation results clearly indicate that
the observed repression plays an important physiological
role, and is required for eﬃcient establishment in new host
cells. This is the ﬁrst demonstration that the repression
part of the regulatory circuit has in vivo signiﬁcance.
DISCUSSION
We present direct in vivo as well as in vitro evidence for
a model of PvuII R-M system regulation that could also
apply to the other RM systems controlled by orthologous
C genes (Figure 1B). In this model, C protein acts as both
transcription activator and repressor for its own gene
(pvuIIC, in this case) and that of the downstream REase
gene (pvuIIR). While bifunctional regulators such as
AraC switch between activation and repression based on
small-molecule coregulators, C.PvuII apparently makes
this switch based on its concentration alone, like the
cI activator-repressor of bacteriophage   (75). Our results
Figure 6. The eﬀects of altered OR on activation and repression by C.PvuII. Quantitative evaluation of selected C.PvuII-activatable variants from the
WWNW and WWNR libraries, upstream of a promoterless cat gene, was determined with C.PvuII produced from PBAD-pvuIIC (pIM4; black bars)
or without pvuIIC (white bars). Furthermore, experiments were carried out at two levels of C.PvuII that, for the WT C-boxes, are respectively
associated with activation (A, upper panel) and repression (B, lower panel). In panel A, cultures were grown in the absence of arabinose, leading to
lower C.PvuII levels, while for panel B, cultures were grown in 0.2% arabinose, associated with high levels of C.PvuII (see Figure 2A). CAT levels
were determined in triplicate immunoassays as described in Material and Methods section. For comparison, variants having inactive OR (WWRR)
or OL (RRWW) were also analyzed. pKK represents vector (pKK232-8) control. The error bars indicate SDs. For each variant, the sequence of
C-half-box 2A is shown (WT=GACT); the horizontal black bar indicates those variants that were selected from the library on the basis of
nonrepressibility. (C) Logo analysis of the nonrepressing variants from the WWNR library, showing the interoperator spacer and C-half-box 2A.
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C.EcoRV (33,45) and suggest that the regulatory switch
depends on C protein occupancy within the C-box region
that, in turn, is highly sensitive to the intracellular C
protein concentration.
Roleof repression in controlof R-M systems suchas PvuII
R-M systems appear to undergo horizontal gene transfer
at a substantial rate (2). C proteins are believed to facili-
tate this process by delaying REase expression, so that the
cognate MTase has time to protectively modify the new
host’s DNA during the establishment in a new cell (40,43).
The delay is thought to be a direct consequence of the
requirement of the pvuIICR promoter for autogenous
activation by C.PvuII. Evidence supporting this view
includes the inability to transform cells with the PvuII
R-M system if the cells already contain a copy of pvuIIC
(13,40). However this delayed activation is apparently
necessary but not suﬃcient to ensure eﬃcient establish-
ment. Our data demonstrate that impairing the repression
portion of the C.PvuII regulatory circuit signiﬁcantly
reduces the eﬃciency with which the entire R-M system
is transferred into new cells (Figure 7B).
By itself, the autogenous activation (positive feedback)
loop of C proteins boosting transcription from their own
promoters should yield an irreversible transition between
two states (76). A purely positive feedback loop is not
necessarily problematic for the cell, as maximal gene
expression levels can be passively limited by the strength
of the promoter and/or translation initiator. One could
even make the argument that once an RM system has
protectively methylated its new host’s DNA, irreversibly
switching on REase production would provide the most
eﬀective defense against bacteriophage infection. Presum-
ably, there is a reason for the use of an active rather than
a passive control mechanism to limit REase levels.
Furthermore, the apparent lack of intermediate species in
C.PvuII binding of WWWW DNA (Figure 3B), and the
high cooperativity of this binding (Figure S2), suggest that
the window between activating and repressing levels
of C.PvuII is extremely narrow. However, the narrowness
of this window is not necessarily problematic. The addi-
tion of a negative feedback element to the positive
feedback circuit would, under some circumstances, result
in an oscillator (76,77). The resultant REase cycling,
that presumably would not aﬀect levels of the MTase,
may allow repeated pulses of highly protective (restriction-
biased) conditions that would lead to chromosome damage
if maintained continuously. On a population level, having
a fraction of the cells hyperrestrictive could protect the
entire population and thus be selectable. The periodic
hyperrestrictive state would, in theory, also strengthen the
genetic addiction (13) to this toxin–antitoxin system. This
hypothesis is consistent with the reduced transformability
by the non-repressing version of the PvuII RM system
(Figure 7B), but requires further testing. An oscillation
model would also predict that the culture-average C.PvuII
level would be between the amounts giving peak activation
and full repression (to the right of the peak in Figure 2B),
in cultures of E. coli carrying the WT PvuII R-M system.
Our preliminary results are consistent with this prediction
(data not shown).
Process of repression
When the DNA for an RM system such as PvuII ﬁrst
enters a new host cell, there is no C protein present.
Figure 7. The eﬀect of mutation in OR on pvuIICR transcription and on PvuII R-M system establishment. The nonrepressing C-box mutation
(WWWR: 50-GACT-CAT-AGTC-TGTA-GACT-CAA-GATC-30) was tested in two ways. (A) In vivo titration with C.PvuII on arabinose inducible
plasmid pIM1, where mutated C-box was fused to lacZ gene (pIM9). Cells were grown in minimal media with 0.2% glycerol, 0.2% glucose and
the indicated concentration of arabinose as described in Figure 2B. The transcriptional activity was measured as b-galactosidase speciﬁc activity as
described in the Figure 2 legend. (B) Equal amounts of three plasmid DNAs were used to determine the eﬃciency of transformation (EOT) in
each of two host strains. The three plasmids were pPvuRM3.4 (WT PvuII R-M system), pIM6 (symmetrized nonrepressing variant), and pBR322
(vector control). These were introduced into competent E. coli TOP10 cells that already carried either the gene for the PvuII MTase (pvuIIM; plasmid
pPvuM1.9-ACYC) or a vector control (pACYC177). Relative EOT was determined as the fraction of M.PvuII
– transformants obtained relative to the
number of transformants for the M.PvuIIM
+ strain, and then normalized to the pBR322 EOT ratio. Error bars indicate the SD.
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of the weak C-independent promoter (Figure 1D) (43).
Based on our mutational and EMSA data (Figure 3B, C),
it appears that as C.PvuII starts to accumulate, OL (half-
boxes 1A and 1B) is occupied ﬁrst. Both its higher aﬃnity,
and its location immediately upstream of the  35 hexamer
for the C-activated promoter (Figure 1D), implicate OL as
the activation site.
As the concentration of C protein continues to rise,
the relative eﬀects of mutation on EMSA behavior
(Figure 3B) suggest that half-box 2A is occupied next,
and ﬁnally half-box 2B. This would be consistent with
results from two other RM systems (33,45,48). At this
point, C protein expression appears to reach its maximum,
and the strong C-dependent promoter dominates pvuIIC/R
transcription. Our experiments indicate that OR is not only
dispensable for activation, but negatively aﬀects
gene expression about 3-fold (compare Q2-WWWW
to R27-WWWR in Figure 6A). Speciﬁcally, reversal of
half-box 2B resulted in a system that was hyperactivated
but not repressed (Figure 6).
Our results do not rule out a role for C.PvuII binding
to half-box 2A in activation, though it overlaps the  35
promoter hexamer. The C proteins are remarkably small
regulatory proteins, with C.PvuII having a subunit MW
of 9.4kDa (41). They have a limited subunit interface
(29,42), and in the case of C.AhdI homodimerization has a
low aﬃnity constant and is substantially stimulated by
binding to adjacent sites on the DNA (45). Thus
occupancy of half-boxes 1A, 1B and 2A (and not 2B)
is possible in theory. The results shown in Figures 3B and
5C and D strongly implicate occupancy of OR (half-boxes
2A and 2B together) in the robust repression shown in
Figure 2A and B. The high-frequency isolation of GACT
variants of half-box 2A, from C.PvuII-activated members
of the WWNR and WWNW libraries, seems inconsistent
with the hypothesis that C.PvuII binding of half-box 2A
plays a role exclusively in repression. In this regard
it is interesting that the binding site for the activator
MuC partially overlaps the  35 hexamer of its activated
promoter (78).
C.PvuII binds to its C-boxes in a cooperative manner
(Figures 3B and S2). This contrasts with the independent
binding of two C.EcoRV dimers to its two operators (33),
but is consistent with the cooperative binding found for
C.AhdI (45). C.EcoRV belongs to a diﬀerent C-protein
family than C.PvuII, and its C-box sequence is substan-
tially diﬀerent from those shown in Figure 1B. However it
is unclear why C.EcoRV binding is noncooperative.
DNA conformation androle ofthe spacer sequences
The spacing between the two C-binding operators
(15bp center-to-center) suggests that two homodimers
interact with the opposite faces of B-form DNA (40). Such
opposite-face interaction has been demonstrated for the
repressor DtxR bound to its operators (79). In the case of
C.AhdI this binding causes local DNA distortion (48).
While the C binding sites are very well conserved
upstream of genes for C protein orthologs (Figure 1B
and C), it is striking that the spacers between C-boxes are
even more strongly conserved, both in sequence and
orientation. This is consistent with studies of the phage
434 repressor, that demonstrated the importance of
a spacer region for operator aﬃnity despite its lack
of speciﬁc contacts to the repressor (80). The spacers are
also presumably responsible for the diﬀerent aﬃnities
of OL and OR for C.PvuII (Figure 3B), as the OL and OR
C-boxes are identical in most of our fusions. Speciﬁcally,
we used the symmetrized consensus shown at the bottom
of Figure 1B, such that half-box 1A=2A and half-box
1B=2B; this involved changing 2/16nt and did not aﬀect
the pattern of response to in vivo titration with C.PvuII
(Figure 2).
The most highly conserved sequence among the all
C-box regions is the central base pairs (GT) of this 4nt
spacer, and speciﬁcally TGTA for the C proteins having
recognition helices with HRTY (Figure 1B and C).
We found that any changes to this tetranucleotide
abolished activation by C.PvuII (Figure 4). However,
in each set of spacer sequences, TGTA with HRTY C
proteins or CGTG with DR
T/SY C proteins, the ﬂanking
(underlined) nucleotides are complementary. This might
indicate, that these nucleotide belong to the C protein
recognition site, as proposed for C.AhdI: GTACT-N3-
AGTCC-GT-GGACT-N3-CGACA (45). However, the
PvuII spacer mutant TGTA!TtTA, which retained
the proposed ﬁfth nucleotide of the binding sites, was
bound by C.PvuII more poorly than the TGTA!cGTA
variant, as judged by the disappearance of unshifted DNA
in (Figure 4F).
Tested variants in the TGTA spacer shared reduced
stability of the shifted complex, as revealed by smearing.
In considering possible explanations for TGTA conserva-
tion, we noticed that TG:CA and TA:AT dinucleotides are
overrepresented in the spacers and the C-box ﬂanking
regions. This overrepresentation is obvious in the logo
derived from 29C-box regions (Figure 1C), 50-TG-N-1A-
TAT-1B-TGTA-2A-TAT-2B-N2-CA-30). These dinucleo-
tide sequences are the most stereochemically ﬂexible,
and confer a propensity for bending during interaction
with dimeric helix–turn–helix proteins (81–84). In addi-
tion, these dinucleotides are frequently located in E. coli
promoters, where they appear to facilitate the isomeriza-
tion step (85). A recent report on C.AhdI–C-box binding
also proposes a structural role for the asymmetrical
operator spacers (CAT and TAT for C.AhdI; CAT and
CAA in the case of C.PvuII) (48). In addition, C.AhdI-
dependent activation involves signiﬁcant twisting of
the speciﬁc binding sites (48). Furthermore, the TGTA
tetranucleotide itself is the single most ﬂexible sequence
among 136 tested with respect to sliding (86), consistent
with its playing a structural role.
Eﬃcient establishment of the PvuII R-M system in
a new host cell requires both the activation (40,43) and
repression arms (this work) of the C.PvuII control circuit.
A full understanding of this regulatory system will require
not only studies of C.PvuII interactions with RNA
polymerase, but also the potential roles of transcriptional
interference (87) between the opposing pvuIICR and
pvuIIM promoters (Figure 1A), and of hybridization
between their transcripts. In addition, little is currently
Nucleic Acids Research, 2007, Vol. 35, No. 20 6949known about how the C-controlled R-M systems respond
to environmental perturbations, or even to which pertur-
bations they have evolved to respond. The C protein-
dependent regulatory systems clearly illustrate the
complexities of even those extant gene regulatory circuits
that only involve a single regulator (88,89). This complex-
ity is perhaps not surprising in a system that must control
both the timing and amount of expression for a potentially
lethal gene.
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Supplementary data are available at NAR Online.
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